Cáncer Renal segunda línea - page 32

Lieu C, et al. ESMO 2014; Abstract 1049

Phase Ib study of Atezolizumab plus

Bevacizumab in first line mRCC

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,22,23,24,25,26,27,28,29,30,31 33,34,35